Adhesion molecules: Key players in mesenchymal stem cell-mediated immunosuppression

Cell Adhesion and Migration

Volumn 5, Issue 1, 2011, Pages 20-22

  Ren, Guangwen ^a   Roberts, Arthur I ^a   Shi, Yufang ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adhesion molecules; Endothelial cells; Immunity; Immunosuppression; Mesenchymal stem cells; T cells

Indexed keywords

ANTIBODY; CHEMOKINE; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE GRAFT VERSUS HOST DISEASE; ADHESION; ANTIGEN PRESENTING CELL; ASTHMA; AUTOIMMUNE DISEASE; CELL ADHESION; CELLULAR IMMUNITY; CONFORMATIONAL TRANSITION; CROHN DISEASE; ENDOTHELIUM; ENDOTHELIUM CELL; ENTERITIS; GLYCOSYLATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER FIBROSIS; MESENCHYMAL STEM CELL; MULTIPLE SCLEROSIS; NEOPLASM; NOTE; PSORIASIS; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SEPSIS; T LYMPHOCYTE;

EID: 78650820946     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.5.1.13491     Document Type: Note

References (30)

1. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007; 218:178-96.
2. von Andrian UH, Chambers JD, Berg EL, Michie SA, Brown DA, Karolak D, et al. L-selectin mediates neutrophil rolling in inflamed venules through sialyl LewisX-dependent and -independent recognition pathways. Blood 1993; 82:182-91.
3. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, et al. Alpha4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995; 80:413-22.
4. Sigal A, Bleijs DA, Grabovsky V, van Vliet SJ, Dwir O, Figdor CG, et al. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J Immunol 2000; 165:442-52.
5. Kanwar S, Bullard DC, Hickey MJ, Smith CW, Beaudet AL, Wolitzky BA, et al. The association between alpha4-integrin, P-selectin and E-selectin in an allergic model of inflammation. J Exp Med 1997; 185:1077-87.
6. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7:678-89. (Pubitemid 47327397)
7. Woodside DG, Vanderslice P. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. BioDrugs 2008; 22:85-100.
8. Bauer RJ, Dedrick RL, White ML, Murray MJ, Garovoy MR. Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis. J Pharmacokinet Biopharm 1999; 27:397-420.
9. Leung Y, Panaccione R. Anti-adhesion molecule strategies for Crohn disease. BioDrugs 2008; 22:259-64.
10. Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003; 348:15-23.
11. Stefanelli T, Malesci A, De La Rue SA, Danese S. Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go. Autoimmun Rev 2008; 7:364-9.
12. Schmidmaier R, Baumann P. ANTI-ADHESION evolves to a promising therapeutic concept in oncology. Curr Med Chem 2008; 15:978-90.
13. Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC, et al. Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med 2005; 353:1912-25.
14. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353:369-74.
15. Harlan JM, Winn RK. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med 2002; 30:214-9.
16. Smith JR, O'Rourke LM, Becker MD, Cao M, Williams KA, Planck SR, et al. Anti-rat ICAM-1 antibody does not influence the course of experimental melanin-induced uveitis. Curr Eye Res 2000; 21: 906-12. (Pubitemid 32209641)
17. Willenborg DO, Simmons RD, Tamatani T, Miyasaka M. ICAM-1-dependent pathway is not critically involved in the inflammatory process of autoimmune encephalomyelitis or in cytokine-induced inflammation of the central nervous system. J Neuroimmunol 1993; 45:147-54.
18. Justicia C, Martin A, Rojas S, Gironella M, Cervera A, Panes J, et al. Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J Cereb Blood Flow Metab 2006; 26:421-32.
19. Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, Ling W, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010; 184:2321-8.
20. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371:1579-86.
21. Abdel Aziz MT, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007; 40:893-9.
22. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15:42-9.
23. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106:1755-61.
24. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008; 10:223.
25. Ren G, Su J, Zhang L, Zhao X, Ling W, L'Huillie A, et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 2009; 27:1954-62.
26. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2:141-50.
27. Lancaster JR Jr. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1997; 1:18-30.
28. Radi R. Nitric oxide, oxidants and protein tyrosine nitration. Proc Natl Acad Sci USA 2004; 101:4003-8.
29. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4:762-74.
30. Quaedackers ME, Baan CC, Weimar W, Hoogduijn MJ. Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes. Eur J Immunol 2009; 39:3436-46.